Lorazepam Dosing for MRI Sedation in Adults

Recommended Dosing Strategy

The American Academy of Family Physicians recommends starting with 1 mg oral lorazepam given 30-60 minutes before the MRI procedure for most adult patients with claustrophobia or anxiety 1
The dose range of 0.5-2 mg is appropriate depending on patient factors including age, weight, prior benzodiazepine exposure, and anxiety severity 1
Elderly patients require dose reduction due to decreased drug metabolism and higher risk of respiratory depression; start with 0.5 mg in patients over 65 years 2

Oral administration is the preferred route for pre-procedural anxiolysis in alert, cooperative patients undergoing non-emergent imaging 1, 2
IV lorazepam (0.5-1 mg administered slowly) may be used if the patient is already in the scanner and becomes acutely anxious, though this requires immediate IV access and monitoring capabilities 2

Continuous oxygen saturation monitoring is mandatory throughout the procedure and recovery period 2, 3, 4
Respiratory support equipment must be immediately available, as benzodiazepines carry increased risk of apnea, particularly when combined with other sedatives 2, 3, 4
Monitor for hypotension, especially in elderly or frail patients 4
Have flumazenil available to reverse life-threatening respiratory depression, though note it will reverse all benzodiazepine effects 2, 3

Do not combine lorazepam with other sedatives or opioids without anesthesia support present, as this dramatically increases apnea risk 2, 3
Avoid doses exceeding 2 mg for outpatient MRI procedures, as higher doses increase risk of prolonged sedation and respiratory depression without proportional anxiolytic benefit 1
Paradoxical agitation occurs in approximately 10% of patients treated with benzodiazepines; if this develops, do not administer additional doses 1
Ensure adequate time for drug onset (30-60 minutes for oral route) to avoid premature re-dosing 1

Patients with hepatic impairment require dose reduction as lorazepam undergoes hepatic metabolism 4
Those with underlying respiratory disease (COPD, sleep apnea) need lower initial doses and more intensive monitoring 4
Patients with a history of substance dependence may require alternative anxiolytic strategies, as benzodiazepines carry addiction risk with regular use 1